… could result in stronger, better funded, respected, and efficient global organisations. Ali Pashazadeh, Treehill Partners CEO, is quoted on Drug Discovery World examining the possible impact from, and expectations by the pharmaceutical sector of, Trump’s second presidency.
Read the full article on Drug Discovery World: